1-8 of 8
Ajeet Gajra, MD, MBBS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Age-Based Disparities in Clinical Trials Supporting FDA Approval of Therapies for Hematologic Malignancies

Ajeet Gajra, MD MBBS, Marjorie E Zettler, PhD MPH, Eli G Phillips, Jr., PharmD, JD, Bruce Feinberg, DO
Journal: Blood
Blood (2020) 136 (Supplement 1): 21–22.
https://doi.org/10.1182/blood-2020-142064
Published: 2020
Journal Articles

Real-World Adverse Events Associated with Tisagenlecleucel in Acute Lymphoblastic Leukemia and Large B-Cell Lymphoma

Marjorie E Zettler, PhD MPH, Bruce Feinberg, DO, Alexandrina Balanean, Ajeet Gajra, MD MBBS
Journal: Blood
Blood (2020) 136 (Supplement 1): 12.
https://doi.org/10.1182/blood-2020-142061
Published: 2020
Journal Articles

Assessment of Measurable Residual Disease (MRD) in Chronic Lymphocytic Leukemia (CLL) and Multiple Myeloma (MM) Among U.S. Community Hematologists/ Oncologists (cH/O)

Ajeet Gajra, MD MBBS, Yamini S Rathish, Yolaine Jeune-Smith, PhD, Andrew J Klink, PhD MPH, Bruce Feinberg, DO
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-142005
Published: 2020
Journal Articles

Adoption of Approved CAR-T Therapies Among US Community Hematologists/ Oncologists

Ajeet Gajra, MD MBBS, Skyler Hime, Yolaine Jeune-Smith, PhD, Bruce Feinberg, DO
Journal: Blood
Blood (2020) 136 (Supplement 1): 34–35.
https://doi.org/10.1182/blood-2020-141990
Published: 2020
Journal Articles

Real-World Use of Enasidenib in Relapsed or Refractory Acute Myeloid Leukemia Is Associated with Reduced Risk of Disease Progression and Death

Andrew J Klink, PhD MPH, Ronda Copher, PhD, Russell L. Knoth, Landon Marshall, PharmD, PhD, Ying Hou, MD, Ajeet Gajra, MD MBBS, Raoul Tibes, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 18.
https://doi.org/10.1182/blood-2020-140005
Published: 2020
Journal Articles

Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS) Associated with PARP Inhibitors: A Real-World Analysis

Ajeet Gajra, MD MBBS, Marjorie E Zettler, PhD MPH, Andrew J Klink, PhD MPH, Bruce Feinberg, DO
Journal: Blood
Blood (2020) 136 (Supplement 1): 19.
https://doi.org/10.1182/blood-2020-142069
Published: 2020
Journal Articles

Utilization Of ADAMTS13 Testing In Suspected Thrombotic Thrombocytopenic Purpura (TTP)

Mijung Lee, MD, Colin A Hardin, MD, Bonnie Chapman, MPH, Steven M. Duffy, MD, Zhanna Spektor, MD, Ajeet Gajra, MD, MBBS
Journal: Blood
Blood (2013) 122 (21): 2953.
https://doi.org/10.1182/blood.V122.21.2953.2953
Published: 2013
Journal Articles

Evaluation Of Laboratory and Clinical Markers For Predicting Survival In TTP/HUS: A Single Center Retrospective Study

Colin A Hardin, MD, Pallawi Torka, MBBS, Veera Durga Panuganty, MBBS, Mijung Lee, MD, Dongliang Wang, PhD, Ajeet Gajra, MD, MBBS
Journal: Blood
Blood (2013) 122 (21): 1082.
https://doi.org/10.1182/blood.V122.21.1082.1082
Published: 2013